Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Drug Manufacturers - Major Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by SamV21on Jan 11, 2022 1:09pm
165 Views
Post# 34304351

Take the time to report pump and dumpers ! as it is illegal

Take the time to report pump and dumpers ! as it is illegal That is the only way we are going to get the truth of this scam. Zero, Zip  communication from the money sucking CEO.How far along is Reduvo, Tetra can contact Health Canada for an update and share with shareholders , nothing and by the way Dronabinol (reduvo) a narcotic which has been around for years and Tetra makes it sound like they invented it , sucking people in . I have seen companies like this before,it is dead quiet just before they shut down.No mention of CEO in the management report that came out in August , 100,000,000 deficit in Tetra report, the truth ,it mentions Tetra could fail in their own report , did pumpers read that report ? no CFO , the truth, undisclosed amounts paid to Intelgenx who is working with Tetra and is in a dispute with Tilray now which is the truth.Why have we never heard from any Medical Doctors about Tetras miracle drugs or the six oclock news about Tetra battles opioids.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities